GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vilin Bio Med VILINBIO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

54.55

—

Close of 5 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2022

Revenue

₹112.1m

FY2020FY2022

Net income

₹335,000

FY2020FY2022

Free cash flow

₹2.1m

FY2020FY2022

Shareholders' equity

₹74.0m

FY2020FY2022

Income statement

Fiscal years

FY2022FY2021FY2020
Revenue₹112.1m₹117.2m₹168.1m
Gross profit₹23.5m₹26.8m₹30.9m
Operating income₹5.5m₹6.0m₹5.9m
Net income₹335,000₹1.2m₹1.6m
Diluted earnings per share0.020.090.12

Balance sheet

At each fiscal year end

FY2022FY2021FY2020
Total assets₹135.6m₹138.9m₹140.1m
Cash and short-term investments₹390,000₹465,000₹666,000
Total liabilities₹61.6m₹65.3m₹67.6m
Debt₹53.0m₹55.2m₹45.3m
Shareholders' equity₹74.0m₹73.6m₹72.4m
Shares outstanding14m14m14m

Cash flow

Fiscal years

FY2022FY2021FY2020
Cash from operations₹2.1m−₹10.0m−₹14.6m
Capital spending——−₹242,000
Free cash flow₹2.1m−₹10.0m−₹14.8m

Latest quarters

By quarter end

Dec 2022
Revenue₹90.1m
Gross profit₹33.4m
Operating income₹21.7m
Net income₹12.8m
Diluted earnings per share0.92
Cash from operations₹65.0m
Total assets₹168.7m
Cash and short-term investments₹355,000
Debt₹5.1m
Shareholders' equity₹86.8m

Average margins

Over each period

1 year3 years5 years10 years
Gross margin21.9%———

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.